75 related articles for article (PubMed ID: 25456909)
1. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors.
Maxwell JE; Sherman SK; Stashek KM; O'Dorisio TM; Bellizzi AM; Howe JR
Surgery; 2014 Dec; 156(6):1359-65; discussion 1365-6. PubMed ID: 25456909
[TBL] [Abstract][Full Text] [Related]
2. Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis.
Watzka FM; Fottner C; Miederer M; Schad A; Weber MM; Otto G; Lang H; Musholt TJ
Langenbecks Arch Surg; 2015 Apr; 400(3):349-58. PubMed ID: 25682055
[TBL] [Abstract][Full Text] [Related]
3. Practical management and treatment of pancreatic neuroendocrine tumors.
Kondo NI; Ikeda Y
Gland Surg; 2014 Nov; 3(4):276-83. PubMed ID: 25493259
[TBL] [Abstract][Full Text] [Related]
4. Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trial.
Lombard-Bohas C; Yao JC; Hobday T; Van Cutsem E; Wolin EM; Panneerselvam A; Stergiopoulos S; Shah MH; Capdevila J; Pommier R
Pancreas; 2015 Mar; 44(2):181-9. PubMed ID: 25479584
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
[TBL] [Abstract][Full Text] [Related]
6. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors.
Cherenfant J; Talamonti MS; Hall CR; Thurow TA; Gage MK; Stocker SJ; Lapin B; Wang E; Silverstein JC; Mangold K; Odeleye M; Kaul KL; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA
Surgery; 2014 Dec; 156(6):1504-10; discussion 1510-1. PubMed ID: 25456943
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
Bellizzi AM
Hum Pathol; 2020 Feb; 96():8-33. PubMed ID: 31857137
[TBL] [Abstract][Full Text] [Related]
8. Prioritization of Fluorescence In Situ Hybridization (FISH) Probes for Differentiating Primary Sites of Neuroendocrine Tumors with Machine Learning.
Pietan L; Vaughn H; Howe JR; Bellizzi AM; Smith BJ; Darbro B; Braun T; Casavant T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139230
[TBL] [Abstract][Full Text] [Related]
9. Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors.
Søreide K; Stättner S; Hallet J
Ann Surg Oncol; 2024 Feb; 31(2):1125-1137. PubMed ID: 38006527
[TBL] [Abstract][Full Text] [Related]
10. Unknown‑primary neuroendocrine neoplasms diagnosed by short‑acting somatostatin test: Case series in one institution.
Chang TK; Su WC; Chen YC; Chen PJ; Li CC; Yeh YS; Huang CW; Tsai HL; Wang JY
Exp Ther Med; 2023 Jan; 25(1):9. PubMed ID: 37081944
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors.
Viehweger F; Tinger LM; Dum D; Gorbokon N; Menz A; Uhlig R; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Krech R; Krech T; Marx AH; Simon R; Burandt E; Steurer S; Sauter G; Minner S; Bernreuther C
Anal Cell Pathol (Amst); 2022; 2022():6412148. PubMed ID: 35992051
[TBL] [Abstract][Full Text] [Related]
12. Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms.
Pastorino L; Grillo F; Albertelli M; Ghiorzo P; Bruno W
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638668
[TBL] [Abstract][Full Text] [Related]
13. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask.
Albertelli M; Grillo F; Lo Calzo F; Puliani G; Rainone C; Colao AAL; Faggiano A;
Front Endocrinol (Lausanne); 2021; 12():680305. PubMed ID: 33967966
[TBL] [Abstract][Full Text] [Related]
14. Small Bowel Neuroendocrine Tumors.
Tran CG; Sherman SK; Howe JR
Curr Probl Surg; 2020 Dec; 57(12):100823. PubMed ID: 33234227
[No Abstract] [Full Text] [Related]
15. Surgical Management of Neuroendocrine Tumor Liver Metastases.
Tran CG; Sherman SK; Chandrasekharan C; Howe JR
Surg Oncol Clin N Am; 2021 Jan; 30(1):39-55. PubMed ID: 33220808
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid Tumors: Past, Present, and Future.
Howe JR
Indian J Surg Oncol; 2020 Jun; 11(2):182-187. PubMed ID: 32523259
[TBL] [Abstract][Full Text] [Related]
17. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
Bellizzi AM
Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
[TBL] [Abstract][Full Text] [Related]
18. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
[TBL] [Abstract][Full Text] [Related]
19. Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary.
Chauhan A; Farooqui Z; Silva SR; Murray A; Hodges KB; Yu Q; Myint ZW; Raajesekar AK; Weiss H; Arnold S; Evers BM; Anthony L
Asian Pac J Cancer Prev; 2019 Jan; 20(1):113-116. PubMed ID: 30678389
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]